96 related articles for article (PubMed ID: 19446975)
1. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
Kasai T; Motoori K; Horikoshi T; Uchiyama K; Yasufuku K; Takiguchi Y; Takahashi F; Kuniyasu Y; Ito H
Eur J Radiol; 2010 Aug; 75(2):143-6. PubMed ID: 19446975
[TBL] [Abstract][Full Text] [Related]
2. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
[TBL] [Abstract][Full Text] [Related]
4. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
Kubota K; Murakami K; Inoue T; Itoh H; Saga T; Shiomi S; Hatazawa J
Ann Nucl Med; 2011 Dec; 25(10):777-86. PubMed ID: 21901365
[TBL] [Abstract][Full Text] [Related]
5. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365
[TBL] [Abstract][Full Text] [Related]
6. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
8. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
10. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
11. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
[TBL] [Abstract][Full Text] [Related]
12. Transbronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography.
Hsu LH; Ko JS; You DL; Liu CC; Chu NM
Respirology; 2007 Nov; 12(6):848-55. PubMed ID: 17986113
[TBL] [Abstract][Full Text] [Related]
13. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM
Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
[TBL] [Abstract][Full Text] [Related]
15. Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?
Wu K; Ung YC; Hwang D; Tsao MS; Darling G; Maziak DE; Tirona R; Mah K; Wong CS
J Nucl Med; 2010 Oct; 51(10):1517-23. PubMed ID: 20847172
[TBL] [Abstract][Full Text] [Related]
16. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
Takenaka D; Ohno Y; Koyama H; Nogami M; Onishi Y; Matsumoto K; Matsumoto S; Yoshikawa T; Sugimura K
Eur J Radiol; 2010 Jun; 74(3):458-64. PubMed ID: 19398291
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Shen G; Hu S; Deng H; Jia Z
Acta Radiol; 2015 Jun; 56(6):681-7. PubMed ID: 24917609
[TBL] [Abstract][Full Text] [Related]
18. Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity.
Hu M; Han A; Xing L; Yang W; Fu Z; Huang C; Zhang P; Kong L; Yu J
Clin Nucl Med; 2011 Jun; 36(6):429-33. PubMed ID: 21552018
[TBL] [Abstract][Full Text] [Related]
19. Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer.
Alkhawaldeh K; Biersack HJ; Henke A; Ezziddin S
Clin Nucl Med; 2011 Jun; 36(6):423-8. PubMed ID: 21552017
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L
Eur J Radiol; 2011 Jan; 77(1):92-6. PubMed ID: 19695804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
